Skip to content
healthcare.dev

ABIRATERONE ACETATE

NDC 42291-073, ABIRATERONE, tablet, from AvKARE.

Product NDC
42291-073
Status
Listed
Labeler
AvKARE
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208327
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42291-073 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE500 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
42291-073-604229100736060 TABLET in 1 BOTTLE (42291-073-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c1200e4e-c4f7-9067-e053-2a95a90af509

Use it

Look up 42291-073 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42291-073 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42291-073. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.